What the research found
The brain appears to encode a "set point" for body weight — essentially a biological baseline that it defends. When you lose weight, your brain registers this as a deviation from that stored reference point and initiates compensatory mechanisms: increased hunger signals, stronger food cravings, and reduced energy expenditure. This isn't a failure of discipline; it's an evolutionary adaptation that helped humans survive periods of food scarcity by resisting sustained weight loss.
Appetite-suppressing medications like GLP-1 agonists work partly by interrupting these hunger signals, which is why they can help maintain a lower weight. However, the underlying set point appears to remain unchanged, meaning these effects may not persist indefinitely once treatment stops.
Why it matters for you
If you've lost weight and then struggled to keep it off despite unchanged diet and training, your brain's weight regulation system is likely working against you—not your adherence. This has practical implications for how you approach fat loss phases. Rather than viewing weight regain as personal failure, it's worth recognising it as a biological push-back that requires either ongoing intervention (whether behavioural, pharmacological, or both) or acceptance of a higher maintenance weight.
For those using GLP-1 peptides or similar agents, this framing suggests that the drugs are buying you time and making adherence easier—not resetting your set point. Planning for what happens after you stop the medication becomes important; some people may need to extend treatment, while others might need to adjust expectations about sustainable weight maintenance.
Caveats
- The source describes a mechanistic framework rather than reporting specific experimental results
- Unclear whether findings are based on human trials, animal models, or computational work
- The concept of metabolic "set point" remains debated in physiology; alternative models exist
- No discussion of how set points might be modified long-term, if at all